拓日新能(002218.SZ):目前的鈣鈦礦電池研發現階段在小面積電池進行新材料、新配方、新結構實驗以及在實際生產線進行量產化實驗
格隆匯7月17日丨有投資者於投資者互動平台向拓日新能(002218.SZ)提問,“貴公司鈣鈦礦太陽能電池研發有什麼進展”,公司回覆稱,公司目前的鈣鈦礦電池研發現階段在小面積電池進行新材料、新配方、新結構實驗以及在實際生產線進行量產化實驗。公司在薄膜電池領域研究較早,而非晶硅和鈣鈦礦都屬於薄膜太陽能電池,在工藝上具有很多相通的地方;另外,產線使用的機械設備基本為公司自制,公司可依託自身的裝備優勢,更靈活地進行方案嘗試,找到正確的工藝後也可用最快的速度和最低的成本擴張。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.